Peptide entry

PT-141

Approved drugPeptide

Also known as: Bremelanotide

Evidence / context

Clinical note: regulated product context exists for bremelanotide; formulation and indication matter.

Available vial formats

PT-141
Vial 10 mgMix 2.0 mLConc 5 mg/mL
  • Conservative 0.5-1.0 mg per use as needed, not daily (10-20 units per injection)
  • Standard 1.25 mg per use as needed, not daily (25 units per injection)
  • Aggressive 1.75 mg per use as needed (35 units per injection); do not exceed 1 dose/24h or 8 doses/month
  • Cycle length On-demand use; reassess tolerability after each use.
  • Best timing At least 45 minutes before intended effect window.

Reconstitution

  1. Swab vial tops with alcohol
  2. Add 2.0 mL bacteriostatic water slowly down the wall
  3. Swirl gently - do not shake
  4. Refrigerate 2-8 C

Dosing, cycle & timing

Timing: Use on-demand rather than as a daily base for most people; trial the first dose on a low-demand day due to nausea risk.

Side effects / tolerability

Notes

Practical tips

Calculate the exact draw for PT-141Preloads your vial and water amount into the calculator.
Open calculator

Related goal guides

Related categories

FAQ

How is PT-141 reconstituted?

1) Swab vial tops with alcohol 2) Add 2.0 mL bacteriostatic water slowly down the wall 3) Swirl gently - do not shake 4) Refrigerate 2-8 C

What is a typical cycle length for PT-141?

On-demand use; reassess tolerability after each use.

How are doses measured in syringe units here?

Units mean U-100 insulin-syringe gradations (1 mL = 100 units), not International Units. Use the calculator to convert a dose into the exact draw for your vial and water amount.

Save this protocolPrintable protocol sheet coming soon.